Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014


#225039

77pages

GlobalData

$ 2500

In Stock


GlobalData's clinical trial report, Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014" provides data on the Microscopic Polyangiitis (MPA) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Microscopic Polyangiitis (MPA). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Microscopic Polyangiitis (MPA). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables4
List of Figures 5

Introduction 6
Microscopic Polyangiitis (MPA) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Microscopic Polyangiitis (MPA) to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Microscopic Polyangiitis (MPA) to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Microscopic Polyangiitis (MPA) 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
F. Hoffmann-La Roche Ltd. 30
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 30
Zenyaku Kogyo Co., Ltd. 31
Clinical Trial Overview of Zenyaku Kogyo Co., Ltd. 31
Teijin Limited 32
Clinical Trial Overview of Teijin Limited 32
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Anthera Pharmaceuticals Inc. 34
Clinical Trial Overview of Anthera Pharmaceuticals Inc. 34
Clinical Trial Overview of Top Institutes / Government 35
Assistance Publique - Hopitaux de Paris 35
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 35
University of Pennsylvania 36
Clinical Trial Overview of University of Pennsylvania 36
Cambridge University Hospitals NHS Foundation Trust 37
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 37
Saitama Medical University 38
Clinical Trial Overview of Saitama Medical University 38
University Hospitals Birmingham NHS Foundation Trust 39
Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust 39
University Medical Center Groningen 40
Clinical Trial Overview of University Medical Center Groningen 40
The National Institute of Allergy and Infectious Diseases 41
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 41
Hospices Civils de Lyon 42
Clinical Trial Overview of Hospices Civils de Lyon 42
University of Oxford 43
Clinical Trial Overview of University of Oxford 43
Massachusetts General Hospital 44
Clinical Trial Overview of Massachusetts General Hospital 44
Five Key Clinical Profiles 45

Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77

Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Microscopic Polyangiitis (MPA) to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Microscopic Polyangiitis (MPA) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Microscopic Polyangiitis (MPA) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Microscopic Polyangiitis (MPA) to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Microscopic Polyangiitis (MPA) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Microscopic Polyangiitis (MPA) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Microscopic Polyangiitis (MPA) Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Microscopic Polyangiitis (MPA) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 30
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zenyaku Kogyo Co., Ltd., 2014* 31
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Teijin Limited, 2014* 32
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals Inc., 2014* 34
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 35
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 36
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2014* 37
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 38
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Birmingham NHS Foundation Trust, 2014* 39
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2014* 40
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 41
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2014* 42
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 43
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 44

Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Microscopic Polyangiitis (MPA) to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Microscopic Polyangiitis (MPA) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Microscopic Polyangiitis (MPA) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Microscopic Polyangiitis (MPA) to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Microscopic Polyangiitis (MPA) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Microscopic Polyangiitis (MPA) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Microscopic Polyangiitis (MPA) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Microscopic Polyangiitis (MPA) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 76